Curaleaf: Analysts Expect Q2 Revenue To Meet Low End Of Guidance

Curaleaf Holdings (CSE: CURA) announced that they will be reporting their second quarter financials after the market closes on August 9.

Analysts have a consensus C$28.28 12-month price target on the company, via a total of 15 analysts, with 5 analysts having strong buy ratings and the other 10 having buy ratings. The street high comes from BTIG with a C$34 price target, and the lowest target comes in at C$24.

13 analysts have revenue estimates for the second quarter. The mean between all 13 is $307.41 million; this number has been revised slightly downwards from $295.79 million at the start of the year. Curaleaf has guided for revenue to come in between $305 – $315 million this quarter. The street high is $314.13 million while the lowest sits at $295.56 million.

Ten analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 51.03%, with this number being flat since the start of the year. Street high goes to MKM Partners with a 58.9% estimate and the lowest sits at 43%.

Onto EBITDA estimates, there are currently 11 analysts who have second quarter EBITDA estimates. The mean is currently $83.85 million, with this number being slightly lower at the start of the year. Street high goes to MKM Partners with a $94.40 million EBITDA estimate and the lowest being a $76.32 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

Valens: Canaccord Cuts Price Target To $4.00 Due To Tapered Growth

On July 13, The Valens Company Inc. (TSX: VLNS) reported its second quarter financial results...

Tuesday, July 19, 2022, 04:56:00 PM

Rogers: “Minority Shareholders Need Closure Not Chaos”

Rogers Communications (TSX: RCI) continues to be the centre of attention within the Canadian markets,...

Sunday, October 31, 2021, 04:56:00 PM

Curaleaf Sees Consensus Estimates Stay Flat After Q1 Results

Curaleaf Holdings (CSE: CURA) reported its first-quarter results on May 10th, beating the consensus estimates...

Saturday, May 15, 2021, 04:24:00 PM

Eldorado Gold: Haywood Reiterates $19.75 Price Target

On December 15th, Eldorado Gold (TSX: ELD) announced the results of the Skouries Project feasibility...

Wednesday, December 29, 2021, 03:31:00 PM

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM